This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By identifying potential new uses for known compounds, AI accelerates the drug repurposing process, bringing new treatments to market faster and at reduced costs. While the benefits of generative AI are evident, ethical considerations and regulatory challenges are to be considered throughout the journey.
The Current Landscape: AI’s Transformative Impact on Healthcare Marketing The healthcare marketing industry is at the forefront of a significant transformation, driven by advances in artificial intelligence (AI). These developments mark only the beginning of what AI can achieve in healthcare marketing.
At a fundamental level, ethical selling is about being transparent — even when it feels risky or uncomfortable. As they weigh purchase options and evaluate vendors, B2B buyers expect sales teams and their companies to behave in ethical ways. . Working with ethical salespeople and companies is a basic requirement among buyers.
Pharmaceutical marketing is evolving rapidly, driven by technological advancements, shifting doctor preferences, and heightened regulatory scrutiny. As we step into 2025, here are the key trends shaping the future of pharmaceutical marketing. Automated marketing workflows streamline communication based on engagement history.
Introduction Social media has become an essential tool for pharmaceutical marketing. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. This article explores the key metrics pharma marketing teams should prioritize to drive success. But which metrics truly matter?
The word influencer was added to the Merriam-Webster dictionary in 2019, but influencer marketing is nothing new. Scandals, fake followers, bot technologies, and the pandemic crisis converged have put a halt to influencer marketing growth and tarnished the public view of influencers as a whole. billion in 2021.
Just as a chef relies on quality ingredients for the perfect dish, marketers depend on cutting-edge research to craft campaigns that resonate with their audience. The Connection Between Pharma Research and Marketing Effective marketing starts with understanding your audience.
But how can marketing teams effectively integrate AI into their strategies? By leveraging machine learning, predictive analytics, and natural language processing (NLP) , pharma companies can gain deeper insights into customer behaviors and market trends. For insights on digital transformation in pharma, visit Pharma Marketing Network.
In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. AI marketing simulators improve forecasting and outcomes, placing customers at the heart of decision-making with new KPIs.
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes.
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Key pillars include: 1.
Table of Contents Sr# Headings 1 Introduction: The Power of Marketing Networks 2 What Are Marketing Networks? In the pharmaceutical industry , harnessing marketing networks is essential to driving successful campaigns. In the pharmaceutical industry , harnessing marketing networks is essential to driving successful campaigns.
Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat.
SUMMARY: Pharma marketing is in a funk. Somewhere over the last decade, the passionate people who believed that helping patients was the first step in excellent marketing have been replaced with people who want to know the ROI of everything. We need more of that and less MBA spreadsheet marketing. ” or “why not?”
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. But how can pharma marketers break through the noise, engage their audience, and see real ROI? Think of digital marketing as the GPS guiding your brand through a crowded, competitive landscape.
Pharma marketing is no longer about mass messaging or relying solely on blockbuster drugs to win the market. Closed-Loop Marketing (CLM) emerges as a transformative approachnot just a strategy but a necessity in todays pharmaceutical environment. What is Closed-Loop Marketing?
With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. Patient-Centric Marketing Patients want to feel heard.
For the past nine years, EVERSANA INTOUCH has done a look ahead: a forecast based on input from leaders on what trends may shape pharma marketing in the year ahead. Lets take a closer look at each of these trends: Applied AI: As excitement continues to grow and AI becomes more real, how is it being deployed by pharma marketers?
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Ethical leadership! Johnson & Johnson has paid $2.7 billion in penalties.
Two days ago, one of the best DTC marketing directors I have ever worked with told me she just resigned. Any reasonable person surely would have raised the red flag a long time ago and asked for further clinical trials or that it be removed from the market. I did it because I wanted to learn ethical pharma marketing.
Influencer marketing is a growing trend in the pharmaceutical industry, as companies look for new and innovative ways to reach their target audiences. As this trend increases, it is important to consider the ethical considerations and best practices for successful influencer marketing in the pharmaceutical industry.
In the context of medical device marketing, VR offers unique opportunities to showcase products, educate stakeholders, and provide immersive experiences that leave a lasting impression. Additionally, regulatory constraints and budget limitations pose significant challenges to traditional marketing efforts.
In this Pharmaceutical Executive video interview, Angela Tenuta, President, Full Service Agencies, at EVERSANA INTOUCH, identifies the most significant ethical concerns related to AI in pharma marketing.
As artificial intelligence (AI) continues to advance, it is becoming increasingly common for pharmaceutical marketers to use AI to write their marketing and customer-facing communications. While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. Floridi, L.
Bridget Seay of epocrates delves into drug launches in a digital-forward market, exploring how pharmaceutical companies can navigate complex patient journeys, strike a balance between traditional and digital marketing tactics, and ethically engage with healthcare professionals and empowered patients amidst ever-changing regulations.
In this article, we will explore the challenges of balancing privacy concerns with targeted ads in pharma marketing. Companies must ensure that they are using customers’ data in an ethical and legal manner. In conclusion, balancing privacy concerns with targeted ads in pharma marketing can be a challenging task.
The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.
In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member explains how pharmaceutical companies can effectively navigate the evolving regulatory landscape and ensure that their marketing activities comply with ethical standards and industry best practices.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. More importantly, how can pharma marketing executives capitalize on these trends to maximize ROI?
Traditionally, pharmaceutical companies have not prioritized emerging markets as part of their access strategy. A Complex and Challenging Environment When companies consider launching medicines in emerging markets, it might be tempting to suggest to simply lower the prices to reflect local affordability.
In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs. There are a number of ways to create patient-centric pharmaceutical marketing.
The ethical and moral questions become “should people who are obese or drink alcohol pay more for their health insurance? Because cancer is a lucrative market. .” So now, in addition to obesity, alcohol is killing us. These findings will probably have. I make the time to exercise via bike riding.
” J&J has had problems in the past, but they’re trying to be an ethical and responsible pharma company. The amount of money Pfizer is going to make from their vaccine borders on obscene while PBMs quietly take a cut of every Rx transaction without really adding any value.
A new generation is coming of age, which is big news for healthcare marketers. Marketers will need to quickly adapt their messaging to this cohort of engaged and discerning consumers, especially as Gen Zers now account for about 20% of the U.S. population and have more than $140 billion in collective spending power.
As they grow more financially independent, they will begin to use their large collective spending power to choose healthcare options that fit their lifestyle, ethics, and personal brand. Here are some marketing strategies that will help ensure your messaging gets in front of Gen Zers. Digital Marketing. Social Media.
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?
Healthcare consumerism has drastically changed the way healthcare professionals need to market and deliver their services. Even if you’re happy with your current patient volumes, healthcare marketing can’t happen without a planned medical marketing strategy to keep your healthcare brand at the forefront of people’s minds.
While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction. Building an Ethical Medical Sales Team?
Whether the expectations for greater transparency are coming from external regulations or their client base, even the most experienced advisors are now feeling the pressure of a rapidly changing financial services market. Many organizations espouse their values on their website, on the walls of their company’s lobby and in marketing material.
But, with all that power, you and I need to pause and think about the ethical side of things. Let’s break down some of the key ethical considerations you and I should keep in mind when using AI in medical sales. But let’s be honest, is it always ethical to let AI decide who gets the most attention?
Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery. (..)
Those business plans were created in Q4 2019, a quarter that started with the continuation of the greatest period of economic expansion and stock market growth in history. In this kind of an environment, it’s also clear how important ethical selling practices are. Has your selling approach changed to reflect this reality?
New drugs, evolving technologies, and emerging marketing channels are creating fresh opportunities for pharma marketing executives. As more patients turn to digital platforms for information and brands compete in an increasingly crowded market, pharma marketers need to be agile, creative, and tech-savvy to succeed.
Companies are invited to reapply each year to be evaluated based on how their policies, actions, and results are impacting the environment, ethics, labor and human rights, and sustainable procurement. Company policies, like the code of ethical conduct, are examples of governance that typically stem from the corporate level.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content